Long-Term Follow-up Study
18 Years and older, Male and Female
LTFS (primary)
NCI-2022-06153
CB-LTSS
Summary
This is an observational, non-interventional, LTFS of investigational Caribou therapies
in patients who have participated in a parent study: a prior Caribou-sponsored clinical
study, special access program, or an IIT. The objective is to evaluate the long-term
safety, through 15 years post infusion, in patients who received IPs in a
Caribou-sponsored clinical study, special access program or IIT.
Objectives
This is an observational, non-interventional, LTFS of investigational Caribou therapies
in patients who have participated in a parent study: a prior Caribou-sponsored clinical
study, special access program, or an IIT. The objective is to evaluate the long-term
safety, through 15 years post infusion, in patients who received IPs in a
Caribou-sponsored clinical study, special access program or IIT.
Eligibility
- Written informed consent (by patient or legal representative) obtained prior to study-specific activities/enrollment
- Completed a Caribou-sponsored study or was administered Caribou IP under a special access program or as part of an IIT
- Use of an effective method of birth control by women of childbearing potential and their partners and men with partners of childbearing potential (partners must also use an effective birth control method) through 12 months post IP infusion.
Treatment Sites in Georgia
**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts...
Click here to learn more about clinical trials.